Company record · CVKD

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics, Inc.'s interim chief financial officer on the record is John P. Sharp, effective June 25, 2026, per the filing record.

Tracked changes

2026-06-29

Cadrenal Therapeutics, Inc. names John P. Sharp interim CFO

2026-06-03

Cadrenal Therapeutics, Inc. names Quang X. Pham interim CFO

This record covers what the tracked filings state; it is not a complete history of the company's finance leadership. Spot an error? Send a correction.